The Role of Neoadjuvant Chemotherapy in Nasopharyngeal Cancer

Rong Yang, Xuhua Li


Nasopharyngeal cancer is a common cancer in Asia as well in North Africa. Though concurrent chemoradiation therapy (CCRT) became standard treatment for advanced NPC patients, some high risk patients still have poor survival. Neoadjuvant chemotherapy has been an option in treatment of NPC. Up until now, there was no solid proof that NCT would positively impact the overall survival (OS) in advanced NPC. Different regimens were compared in the literatures, NCT plus radiation (RT) did not show improvement in OS as compared to RT alone, as well as NCT plus CCRT did not show benefit as compared to CCRT or CCRT plus adjuvant chemotherapy (ACT). Some trends of improving disease free survival (DFS) or distant recurrence free survival were observed, especially in certain group of patient with large local tumor or lymph nodes. More studies which focus on standard NCT regimen and narrowing down the target patients will be needed to further investigate the value of NCT in treatment of NPC.

Full Text:

PDF Citation



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

eISSN: 2312-0398

Asia Press is a professional Science, Technology and Medicine publisher, who owns rapid publication, Peer-Reviewed, Open Access Journals. Asia Press aims to promote “knowledge sharing”. As you know, the main barrier for free “knowledge sharing” is the cost of publishing and transfer. In order to encourage scholars and scientists to the max, and devote whole power to realize the aim of “knowledge sharing” and the benefit of “all” mankind, Asia Press performs a permanent policy of no charge for publication and access, and always open its door for authors worldwide.

© 2013-2017 by the Asia Press. All rights reserved.